Rachel A.

Rachel A. has a diverse work experience in the pharmaceutical and medical field. Rachel is currently working as the VP of Clinical Development at Leap Therapeutics since September 2022. Prior to that, they held the position of VP of Oncology Development at Gossamer Bio from September 2021 to January 2022. Rachel also has experience with Merck, where they were an Executive Director from December 2020 to September 2021 and a Senior Medical Director from May 2016 to December 2020. Rachel has also worked as a Medical Director at Bristol Myers Squibb from June 2014 to May 2016. Rachel's career began as an Assistant Professor at The Ohio State University Wexner Medical Center in January 1999, and they later became an Associate Professor at The Warren Alpert Medical School of Brown University from January 2007 to June 2014.

Rachel A. has a Doctor of Medicine (MD) degree from Washington University in St. Louis. Prior to that, they obtained a Bachelor of Arts (BA) degree in Biochemistry from Brandeis University.